ODDB.org: Open Drug Database

Swissmedic Registration	69599	Date of registration	06.02.2025
Company name	Neuraxpharm Switzerland AG	Revision date
		Valid until	05.02.2030
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	07.15.	Information for professionals

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Briumvi 25 mg/ml	Konzentrat zur Herstellung einer Infusionslösung	Concentrate for infusion (Ublituximabum 150mg / 6ml)

2025	©ywesee GmbH